✦ LIBER ✦

Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease

✍ Scribed by George V. Papatheodoridis; Evangelini Dimou; Andreas Laras; Vassilios Papadimitropoulos; Stephanos J. Hadziyannis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Course of virologic breakthroughs under

✍ Papatheodoridis, George V.; Dimou, Evangelini; Papadimitropoulos, Vassilios; Had 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Course of virologic breakthroughs (VBTs)

✍ G.V. Papatheodoridis; E. Dimou; V. Papadimitropoulos; A. Laras; S. Hadziyannis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Long term lamivudine therapy in patients

✍ Themistoklis Vasiliadis; Kalliopi Patsiaoura; Adamos Saveriadis; Despina Kolokot 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Long-term lamivudine monotherapy (LAM) i

✍ George Papatheodoridis; Evangelini Dimou; Andreas Laras; Vasilios Papadimitropou 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Diferences in virological and biochemica

✍ Themistoklis Vasiliadis; Kaliopi Patsiaoura; Adamos Saveriadis; Despina Kolokotr 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Characteristics and outcome of biochemic

✍ George Papatheodoridis; Evangelini Dimou; Andreas Laras; Vasilios Papadimitropou 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 114 KB